Retatrutide vs. Mounjaro: Which Weight-Loss Drug Works Better in 2025?
Retatrutide vs. Mounjaro: Which Weight-Loss Medication Is Better? As new anti-obesity medications continue to emerge, two names dominate the conversation: Retatrutide and Mounjaro. If you’re researching weight-loss injections, understanding how these two treatments compare can help you make an informed decision. What Is Retatrutide? Retatrutide is an investigational triple-agonist that targets GIP, GLP-1, and glucagon receptors. It is currently being studied for obesity, type 2 diabetes, and metabolic disorders. Early clinical trials show unprecedented weight-loss results, making it one of the most anticipated medications in development. Key points about Retatrutide: Not FDA-approved yet Works on three metabolic pathways Showing very high...
Read more...
